Polaryx Therapeutics Statistics

NASDAQ: PLYXHealthcareBiotechnologyUSD

2.00-0.09 (-4.31%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Polaryx Therapeutics by the numbers

Polaryx Therapeutics has a market capitalization of $99.7 million based on 49.85M shares outstanding. With trailing EPS of $-0.14, Polaryx Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.2% below its 50-day average and 47.6% below its 200-day average.

Average daily trading volume is 76.41K shares, or about $152,820 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PLYX valuation vs. peer median

PLYX compared with the median of 8 peer companies
Metric	PLYX	Peer median	Difference
Market cap	$99.69M	$100.97M	-1%
Avg. volume	76.41K	273.54K	-72%

Peer median across 8 companies: PYPD, BMEA, KZIA, ANIX, CRBP, CNXU, AARD, IMUX.

Valuation

Market cap: $99.69M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-0.14
Shares outstanding: 49.85M

Price and trading

Previous close: 2.09
Open: 2.01
Day range: 1.86 – 2.02
52-week range: 1.85 – 48.91
50-day moving average: 2.11
200-day moving average: 3.81
Beta: —
Volume: 160.69K
Average volume: 76.41K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 99.69M
Eps: -0.14
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 48.91
Week52 Low: 1.85
Avg Volume: 76,410.00
Shares Outstanding: 49.85M
Ma50: 2.11
Ma200: 3.81
Pct From52w High: -95.91%
Pct From52w Low: 8.11%